| Genomic and proteomic studies have produced a flood of targets for investigation. Once these targets have been validated, the challenge remains to create functional pharmaceutical compounds. Advances in structure-guided design, combinatorial chemistry and high-throughput screening have accelerated the identification of druggable targets. Evolving techniques in synthetic organic chemistry have enabled medicinal and process chemists to produce increasingly complex molecules with great efficiency and economy. However, competitive pharmaceutical markets demand even greater increases in the number of successful clinical candidates to sustain business. CHI’s Chemistry conference series aims to bring together industry thought leaders from the pharmaceutical and biotech sectors along with academic and government experts to address critical issues in all business and scientific aspects of chemistry in pharmaceutical and biotech industries. |
|
|
